NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
NPCE on Nasdaq
Shares outstanding
33,235,472
Price per share
$15.44
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
25,945,404
Total reported value
$267,500,978
% of total 13F portfolios
0%
Share change
+3,427,984
Value change
+$34,175,646
Number of holders
80
Price from insider filings
$15.44
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Polar Capital Holdings Plc 9.1% $34,534,675 2,972,003 Polar Capital Holdings Plc 31 Mar 2025
Soleus Private Equity Fund I, L.P. 8.9% $30,496,537 2,957,957 Guy Levy 30 Sep 2025
ORBIMED ADVISORS LLC 8% -23% $26,716,960 -$8,095,783 2,614,184 -23% OrbiMed Advisors LLC 30 Jun 2025
MORGAN STANLEY 8.3% $28,926,723 2,489,391 Morgan Stanley 31 Dec 2024
Soleus Capital Master Fund, L.P. 7% $23,545,122 2,303,828 Soleus Capital Management, L.P. 30 Jun 2025
Kent Lake PR LLC 4.9% -2% $17,227,289 +$116,944 1,482,555 +0.68% Kent Lake PR LLC 31 Dec 2024

As of 30 Sep 2025, 80 institutional investors reported holding 25,945,404 shares of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE). This represents 78% of the company’s total 33,235,472 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) together control 74% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Polar Capital Holdings Plc 9.3% 3,097,868 0.15% $31,939,019
Soleus Capital Management, L.P. 8.9% 2,957,957 +28% 1.6% $30,496,537
ORBIMED ADVISORS LLC 7.9% 2,614,184 0% 0.65% $26,952,237
MORGAN STANLEY 7.7% 2,546,208 -1.5% 0% $26,251,405
BlackRock, Inc. 7.3% 2,416,653 +4.2% 0% $24,915,691
VANGUARD GROUP INC 4.3% 1,435,850 +4.9% 0% $14,803,614
First Light Asset Management, LLC 4.1% 1,360,071 -1.5% 1.3% $14,022,332
ARMISTICE CAPITAL, LLC 3.9% 1,298,000 +13% 0.42% $13,382,380
Kent Lake PR LLC 3% 1,000,000 +8.1% 5.3% $10,310,000
Driehaus Capital Management LLC 2.8% 939,519 -6.5% 0.07% $9,686,441
DEUTSCHE BANK AG\ 2.8% 928,766 0% 0% $9,575,578
FMR LLC 1.9% 624,322 -0.18% 0% $6,436,760
GEODE CAPITAL MANAGEMENT, LLC 1.7% 559,732 +15% 0% $5,771,692
STATE STREET CORP 1.2% 407,839 +11% 0% $4,204,820
SILVERCREST ASSET MANAGEMENT GROUP LLC 0.9% 299,387 +0.21% 0.02% $3,086,680
Nantahala Capital Management, LLC 0.89% 295,089 0% 0.19% $3,042,368
Divisadero Street Capital Management, LP 0.88% 292,792 +21% 0.14% $3,018,686
NORTHERN TRUST CORP 0.71% 236,451 +1.9% 0% $2,437,809
ESSEX INVESTMENT MANAGEMENT CO LLC 0.65% 216,722 +194% 0.34% $2,234,404
Qube Research & Technologies Ltd 0.64% 213,773 +90% 0% $2,204,000
Palumbo Wealth Management LLC 0.59% 197,476 +16% 0.66% $2,035,978
GOLDMAN SACHS GROUP INC 0.56% 186,538 +218% 0% $1,923,207
TUDOR INVESTMENT CORP ET AL 0.46% 153,698 +29% 0.01% $1,584,626
RENAISSANCE TECHNOLOGIES LLC 0.39% 129,100 -0.01% 0% $1,331,021
LAZARD ASSET MANAGEMENT LLC 0.32% 105,089 +33% 0% $1,083,468

Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 221,869 $3,426,175 +$375,972 $15.44 5
2025 Q3 25,945,404 $267,500,978 +$34,175,646 $10.31 80
2025 Q2 22,505,448 $250,711,399 -$19,749,912 $11.14 98
2025 Q1 23,932,784 $294,127,661 +$42,108,506 $12.29 89
2024 Q4 20,868,828 $233,522,000 +$8,990,314 $11.19 61
2024 Q3 14,795,861 $103,125,040 +$1,471,249 $6.97 48
2024 Q2 14,430,601 $109,095,635 +$4,457,712 $7.56 51
2024 Q1 13,364,973 $176,414,273 +$9,053,052 $13.20 53
2023 Q4 12,690,314 $130,836,764 +$2,444,618 $10.31 41
2023 Q3 18,073,997 $175,859,892 +$5,454,271 $9.73 24
2023 Q2 17,503,080 $78,589,150 -$756,243 $4.49 20
2023 Q1 17,670,188 $81,990,736 +$1,754,483 $4.64 24
2022 Q4 17,357,024 $25,862,002 -$2,680,436 $1.49 22
2022 Q3 18,161,017 $68,102,000 -$1,024,177 $3.75 27
2022 Q2 18,426,044 $91,207,000 -$26,340 $4.95 26
2022 Q1 18,210,639 $149,512,180 -$117,404 $8.21 37
2021 Q4 18,012,051 $181,543,000 +$1,949,052 $10.08 41
2021 Q3 11,190,051 $177,393,000 +$509,015 $15.85 39
2021 Q2 10,905,701 $259,451,000 +$259,451,000 $23.79 44